SEARCH

SEARCH BY CITATION

Literature Cited

  • Ackland ML, Michalczyk A, Whitehead RH. 2001. PMC42, a novel model for the differentiated human breast. Exp Cell Res 263: 1422.
  • Ackland ML, Newgreen D, Price JT, Fridman M, Waltham M, Arvanitis A, Minichiello J, Thompson EW. 2003a. Epidermal growth factor stimulates epithelio-mesenchymal transition in the stable human breast carcinoma cell line variant PMC42-LA. Lab Invest 83: 435448.
  • Ackland ML, Ward J, Ackland CM, Greaves M, Walker M. 2003b. Extracellular matrix induces formation of organoids and changes in cell surface morphology in cultured human breast carcinoma cells PMC42-LA. In Vitro Cell Dev Biol Anim 39: 428433.
  • Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL. 2006. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 66: 33653369.
  • Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD. 1999. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96: 62496254.
  • Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. 2000. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 8489.
  • Benahmed F, Gross I, Guenot D, Jehan F, Martin E, Domon-Dell C, Brabletz T, Kedinger M, Freund JN, Duluc I. 2007. The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells. Am J Pathol 170: 733744.
  • Bhowmick NA, Neilson EG, Moses HL. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432: 332337.
  • Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. 2003. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 116: 499511.
  • Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. 1998. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701704.
  • Chaffer CL, Dopheide B, McCulloch DR, Lee AB, Moseley JM, Thompson EW, Williams ED. 2005. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 22: 115125.
  • Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. 2006. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Res 66: 1127111278.
  • Chaffer CL, Thompson EW, Williams ED. 2007. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 185: 719.
  • Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, Bertucci F. 2006. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25: 22732284.
  • Christiansen JJ, Rajasekaran AK. 2006. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 83198326.
  • Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor REB, Amir S, Lubaroff DM, Heidger PM, Jr, Hendrix MJC. 2004. Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 91: 649661.
  • Come C, Arnoux V, Bibeau F, Savagner P. 2004. Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia 9: 183193.
  • Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P. 2006. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 12: 53955402.
  • de Iongh RU, Wederell E, Lovicu FJ, McAvoy JW. 2005. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: A model for cataract formation. Cells Tissues Organs 179: 4355.
  • Derycke L, De Wever O, Stove V, Vanhoecke B, Delanghe J, Depypere H, Bracke M. 2006. Soluble N-cadherin in human biological fluids. Int J Cancer 119: 28952900.
  • Desmouliere A. 1995. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 19: 471476.
  • Deyrup AT, Montag AG. 2007. Epithelioid and epithelial neoplasms of bone. Arch Pathol Lab Med 131: 205216.
  • Duband JL, Monier F, Delannet M, Newgreen D. 1995. Epithelium-mesenchyme transition during neural crest development. Acta Anat (Basel) 154: 6378.
  • Dudas M, Li WY, Kim J, Yang A, Kaartinen V. 2007. Palatal fusion—where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem 109: 114.
  • Dvorak HF. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 16501659.
  • Fodde R, Brabletz T. 2007. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150158.
  • Franci C, Takkunen M, Dave N, Alameda F, Gomez S, Rodriguez R, Escriva M, Montserrat-Sentis B, Baro T, Garrido M, Bonilla F, Virtanen I, Garcia de Herreros A. 2006. Expression of Snail protein in tumor-stroma interface. Oncogene 25: 51345144.
  • Gao X, Chung LW, Nie S. 2007. Quantum dots for in vivo molecular and cellular imaging. Methods Mol Biol 374: 135146.
  • Gilles C, Polette M, Piette J, Delvigne AC, Thompson EW, Foidart JM, Birembaut P. 1996. Vimentin expression in cervical carcinomas: Association with invasive and migratory potential. J Pathol 180: 175180.
  • Gilles C, Polette M, Zahm J, Tournier J, Volders L, Foidart J, Birembaut P. 1999. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 46154625.
  • Giunciuglio D, Culty M, Fassina G, Masiello L, Melchiori A, Paglialunga G, Arand G, Ciardiello F, Basolo F, Thompson EW., et al. 1995. Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer 63: 815822.
  • Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA. 2007. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res 67: 42194226.
  • Hay ED. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154: 820.
  • Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. 2000. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148: 779790.
  • Hlubek F, Spaderna S, Schmalhofer O, Jung A, Kirchner T, Brabletz T. 2007. Wnt/FZD signaling and colorectal cancer morphogenesis. Front Biosci 12: 458470.
  • Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. 2002. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99: 365370.
  • Ip YT, Gridley T. 2002. Cell movements during gastrulation: Snail dependent and independent pathways. Curr Opin Genet Dev 12: 423429.
  • Ishikawa S, Kaneko H, Sumida T, Sekiya M. 1979. Ultrastructure of mesodermal mixed tumor of the uterus. Acta Pathol Jpn 29: 801809.
  • Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341350.
  • Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M. 2007. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: Special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol 31: 8594.
  • Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM, Balaji KC. 2006. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66: 193199.
  • Jennbacken K, Gustavsson H, Welen K, Vallbo C, Damber JE. 2006. Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. Prostate 66: 16311640.
  • Jiang R, Lan Y, Norton CR, Sundberg JP, Gridley T. 1998. The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol 198: 277285.
  • Kahn LB, Uys CJ, Dale J, Rutherfoord S. 1978. Carcinoma of the breast with metaplasia to chondrosarcoma: A light and electron microscopic study. Histopathology 2: 93106.
  • Kalluri R, Neilson EG. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 17761784.
  • Kang Y, Massague J. 2004. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118: 277279.
  • Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA. 2004. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707712.
  • Klymkowsky MW. 2005. Beta-catenin and its regulatory network. Hum Pathol 36: 225227.
  • Kokinnos M, Wafai R, Wong M, Newgreen D, Thompson E, Waltham M. 2007. Vimentin and epithelial-to-mesenchymal transition in human breast cancer—observations in vitro and in vivo. Cells Tissues Organs 185: in press
  • Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest PJ, Brandt B, Boecker W, Buerger H. 2005. The origin of vimentin expression in invasive breast cancer: Epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206: 451457.
  • Krug EL, Mjaatvedt CH, Markwald RR. 1987. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Dev Biol 120: 348355.
  • Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, Chua CW, Chan KW, Chan FL, Glackin C, Wong YC, Wang X. 2005. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65: 51535162.
  • Lacroix M, Leclercq G. 2004. Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat 83: 249289.
  • Lappin DW, McMahon R, Murphy M, Brady HR. 2002. Gremlin: An example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant 17: 6567.
  • Lawrence M, Veveris-Lowe T, Whitbread A, Nicol DL, Clements JA. 2007. Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases. Cells Tissues Organs 185: 111115.
  • Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. 1993. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90: 9991003.
  • Lebret SC, Newgreen DF, Waltham MC, Price JT, Thompson EW, Ackland ML. 2006. Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells. In Vitro Cell Dev Biol Anim 42: 298307.
  • Lebret SC, Newgreen DF, Thompson EW, Ackland ML. 2007. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res 9: R19.
  • Li CM, Guo M, Borczuk A, Powell CA, Wei M, Thaker HM, Friedman R, Klein U, Tycko B. 2002. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160: 21812190.
  • Liem KF, Jr, Tremml G, Roelink H, Jessell TM. 1995. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82: 969979.
  • Loric S, Paradis V, Gala JL, Berteau P, Bedossa P, Benoit G, Eschwege P. 2001. Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer. Eur J Cancer 37: 14751481.
  • Lu Z, Ghosh S, Wang Z, Hunter T. 2003. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499515.
  • Mason MD, Davies G, Jiang WG. 2002. Cell adhesion molecules and adhesion abnormalities in prostate cancer. Crit Rev Oncol Hematol 41: 1128.
  • McAlhany SJ, Ayala GE, Frolov A, Ressler SJ, Wheeler TM, Watson JE, Collins C, Rowley DR. 2004. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate 61: 182191.
  • Monaghan P, Whitehead RH, Perusinghe N, O'Hare MJ. 1985. An immunocytochemical and ultrastructural study of heterogeneity in the human breast carcinoma cell line P MC42. Cancer Res 45: 50885097.
  • Monsoro-Burq AH, Fletcher RB, Harland RM. 2003. Neural crest induction by paraxial mesoderm in Xenopus embryos requires FGF signals. Development 130: 31113124.
  • Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. 2005. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197209.
  • Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A, Kandpal RP. 2006. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: Comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25: 23282338.
  • Nawshad A, Medici D, Liu CC, Hay ED. 2007. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 120: 16461653.
  • Nelson WJ, Nusse R. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 14831487.
  • Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515527.
  • Newgreen DF, Erickson CA. 1986. The migration of neural crest cells. Int Rev Cytol 103: 89145.
  • Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. 1999. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631644.
  • Oltean S, Sorg BS, Albrecht T, Bonano VI, Brazas RM, Dewhirst MW, Garcia-Blanco MA. 2006. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci USA 103: 1411614121.
  • Pantel K, Felber E, Schlimok G. 1994. Detection and characterization of residual disease in breast cancer. J Hematother 3: 315322.
  • Rae JM, Ramus SJ, Waltham M, Armes JE, Campbell IG, Clarke R, Barndt RJ, Johnson MD, Thompson EW. 2004. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis 21: 543552.
  • Ray ME, Mehra R, Sandler HM, Daignault S, Shah RB. 2006. E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes. J Urol 176: 14091414.
  • Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, Hofler H, Sarbia M. 2006. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch 448: 277287.
  • Saegusa M, Hashimura M, Kuwata T, Hamano M, Wani Y, Okayasu I. 2007. A functional role of Cdx2 in {beta}-catenin signaling during trans-differentiation in endometrial carcinomas. Carcinogenesis Apr 29 [Epub ahead of print].
  • Saito T, Nagai M, Ladanyi M. 2006. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: A potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. Cancer Res 66: 69196927.
  • Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ. 1994. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 91: 56575661.
  • Sefton M, Sanchez S, Nieto MA. 1998. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 125: 31113121.
  • Shuler CF. 1995. Programmed cell death and cell transformation in craniofacial development. Crit Rev Oral Biol Med 6: 202217.
  • Sommers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP. 1992. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52: 51905197.
  • Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. 1994. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325335.
  • Summerbell D, Rigby PW. 2000. Transcriptional regulation during somitogenesis. Curr Top Dev Biol 48: 301318.
  • Tarin D, Thompson EW, Newgreen DF. 2005. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65: 59966000.
  • Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131142.
  • Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME., et al. 1992. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534544.
  • Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, Martin GR, Lippman ME, Stampfer MR, Dickson RB. 1994. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis 12: 181194.
  • Thompson EW, Waltham M, Ramus SJ, Hutchins AM, Armes JE, Campbell IG, Williams ED, Thompson PR, Rae JM, Johnson MD, Clarke R. 2004. LCC15-MB cells are MDA-MB-435: A review of misidentified breast and prostate cell lines. Clin Exp Metastasis 21: 535541.
  • Thompson EW, Newgreen DF, Tarin D. 2005. Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition? Cancer Res 65: 59915995.
  • Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA. 2000. Cadherin switching in human prostate cancer progression. Cancer Res 60: 36503654.
  • Vallin J, Thuret R, Giacomello E, Faraldo MM, Thiery JP, Broders F. 2001. Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta-catenin signaling. J Biol Chem 276: 3035030358.
  • van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530536.
  • Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA. 2005. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer 12: 631643.
  • Vicovac L, Aplin JD. 1996. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat (Basel) 156: 202216.
  • Vincan E, Darcy PK, Farrelly CA, Faux MC, Brabletz T, Ramsay RG. 2007. Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids. Oncogene 26: 23402352.
  • Wells CM, Ahmed T, Masters JR, Jones GE. 2005. Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering. Cell Motil Cytoskeleton 62: 180194.
  • Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA. 2006. The role of kallikrein-related peptidases in prostate cancer: Potential involvement in an epithelial to mesenchymal transition. Biol Chem 387: 707714.
  • Whitehead RH, Bertoncello I, Webber LM, Pedersen JS. 1983a. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization. J Natl Cancer Inst 70: 649661.
  • Whitehead RH, Monaghan P, Webber LM, Bertoncello I, Vitali AA. 1983b. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. II. Characterization of cells growing as organoids. J Natl Cancer Inst 71: 11931203.
  • Whitehead RH, Quirk SJ, Vitali AA, Funder JW, Sutherland RL, Murphy LC. 1984. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst 73: 643648.
  • Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K. 2005. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11: 80068014.
  • Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, Chung LW, Zhau HE. 2006. Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66: 16641673.
  • Xue C, Plieth D, Venkov C, Xu C, Neilson EG. 2003. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63: 33863394.
  • Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927939.
  • Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. 2005. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65: 57695777.
  • Yates CC, Shepard CR, Stolz DB, Wells A. 2007. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96: 12461252.
  • Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH. 2001. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61: 51685178.